These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17786456)

  • 1. Tauopathy models and human neuropathology: similarities and differences.
    Frank S; Clavaguera F; Tolnay M
    Acta Neuropathol; 2008 Jan; 115(1):39-53. PubMed ID: 17786456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
    Williams DR
    Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropathology of tauopathies and synucleinopathies, and neuroanatomy of sleep disorders: meeting the challenge].
    Hauw JJ; Hausser-Hauw C; Duyckaerts C
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S59-70. PubMed ID: 14646802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited review: Neuropathology of tauopathies: principles and practice.
    Kovacs GG
    Neuropathol Appl Neurobiol; 2015 Feb; 41(1):3-23. PubMed ID: 25495175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying tauopathies in Drosophila: A fruitful model.
    Sun M; Chen L
    Exp Neurol; 2015 Dec; 274(Pt A):52-7. PubMed ID: 25862286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies.
    Zilka N; Korenova M; Novak M
    Acta Neuropathol; 2009 Jul; 118(1):71-86. PubMed ID: 19238406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Animal models of tauopathies].
    Higuchi M
    Rinsho Shinkeigaku; 2006 Nov; 46(11):928-30. PubMed ID: 17432223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome subunit proteins and neuropathology in tauopathies and synucleinopathies: Consequences for proteomic analyses.
    Zouambia M; Fischer DF; Hobo B; De Vos RA; Hol EM; Varndell IM; Sheppard PW; Van Leeuwen FW
    Proteomics; 2008 Mar; 8(6):1221-36. PubMed ID: 18283660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of the tauopathies.
    Murray B; Lynch T; Farrell M
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):595-9. PubMed ID: 16042552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load.
    Koson P; Zilka N; Kovac A; Kovacech B; Korenova M; Filipcik P; Novak M
    Eur J Neurosci; 2008 Jul; 28(2):239-46. PubMed ID: 18702695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurogenesis and cell cycle-reactivated neuronal death during pathogenic tau aggregation.
    Schindowski K; Belarbi K; Bretteville A; Ando K; Buée L
    Genes Brain Behav; 2008 Feb; 7 Suppl 1(1):92-100. PubMed ID: 18184373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditionally inducible tau mice--designing a better mouse model of neurodegenerative diseases.
    Janus C
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():12-27. PubMed ID: 18184367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic zebrafish models of neurodegenerative diseases.
    Sager JJ; Bai Q; Burton EA
    Brain Struct Funct; 2010 Mar; 214(2-3):285-302. PubMed ID: 20162303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knock-out and transgenic mouse models of tauopathies.
    Denk F; Wade-Martins R
    Neurobiol Aging; 2009 Jan; 30(1):1-13. PubMed ID: 17590238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy.
    Zilka N; Stozicka Z; Kovac A; Pilipcinec E; Bugos O; Novak M
    J Neuroimmunol; 2009 Apr; 209(1-2):16-25. PubMed ID: 19232747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Functional Role of microRNAs in the Pathogenesis of Tauopathy.
    Praticò D
    Cells; 2020 Oct; 9(10):. PubMed ID: 33050194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies.
    Leem YH; Lim HJ; Shim SB; Cho JY; Kim BS; Han PL
    J Neurosci Res; 2009 Aug; 87(11):2561-70. PubMed ID: 19360903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argyrophilic grain disease: a late-onset dementia with distinctive features among tauopathies.
    Tolnay M; Clavaguera F
    Neuropathology; 2004 Dec; 24(4):269-83. PubMed ID: 15641585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.